Starling Oncology (STLNW) Net Margin (2021 - 2026)
Starling Oncology's (STLNW) quarterly Net Margin came in at 5.11% in Q2 2026, up 657.0% on a YoY basis from 0.67% in Q2 2025, and down 259.78% quarter-over-quarter from 1.42% in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) Net Margin (2021 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported Net Margin for 6 consecutive years, with 5.11% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 657.0% year-over-year to 5.11%; the trailing twelve-month figure through Jun 2026 stood at 5.2% (up 755.0% YoY), and the FY2025 full-year result was 10.01%, up 347.0% from the prior year.
- Net Margin slipped to 5.11% in Q2 2026 per STLNW's latest filing, from 1.42% in the prior quarter.
- Across five years, Net Margin topped out at 34.96% in Q1 2022 and bottomed at 39.37% in Q1 2023.
- Historically, Net Margin has averaged 11.29% across 5 years, with a median of 12.27% in 2024.
- The sharpest annual moves came in 2022 and 2023: Net Margin soared 2323 bps in 2022, then tumbled 7433 bps in 2023.
- Over 5 years, Net Margin stood at 15.41% in 2022, then slumped by 42 bps to 21.86% in 2023, then soared by 51 bps to 10.8% in 2024, then jumped by 58 bps to 4.53% in 2025, then slipped by 13 bps to 5.11% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 5.11%, 1.42%, and 4.53% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.89 Bn | 11.20 Bn | 1.16 Bn | 9.66% |
| 2 | RadNet | 5.51 Bn | 4.78 Bn | 88.08 Mn | 3.25% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 4.49% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 11.10% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 1.54% |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - | 8.17% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 8.00% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 3.50% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 6.96% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -5.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.11% |
| Mar 31, 2026 | -1.42% |
| Dec 31, 2025 | -4.53% |
| Sep 30, 2025 | -10.08% |
| Jun 30, 2025 | -11.68% |
| Mar 31, 2025 | -15.40% |
| Dec 31, 2024 | -10.80% |
| Sep 30, 2024 | -13.24% |
| Jun 30, 2024 | -12.86% |
| Mar 31, 2024 | -21.01% |
| Dec 31, 2023 | -21.86% |
| Sep 30, 2023 | -21.23% |
| Jun 30, 2023 | -21.06% |
| Mar 31, 2023 | -39.37% |
| Dec 31, 2022 | -15.41% |
| Sep 30, 2022 | -4.12% |
| Jun 30, 2022 | -8.95% |
| Mar 31, 2022 | 34.96% |
| Dec 31, 2021 | -18.99% |
| Sep 30, 2021 | -0.66% |